Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More | Sarah de Crescenzo | 11/15/19 | National |
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More | Frank Vinluan | 08/02/19 | National |
Upjohn & Mylan to Merge, Freeing Pfizer to Focus on Biopharma R&D | Frank Vinluan | 07/29/19 | New York |
Pharma Plays The “Value” Card: Drug Spending Then And Now | Stewart Lyman | 09/14/15 | National |
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief | Ben Fidler | 09/07/14 | Boston |
Which Countries Excel in Creating New Drugs? It’s Complicated | Stewart Lyman | 09/02/14 | Seattle |
Metabolic Solutions Announces New Findings in Diabetes Treatment | Sarah Schmid Stevenson | 06/12/12 | Detroit Ann Arbor |